Cytokines as suppressors of apoptosis

被引:36
作者
Lotem, J [1 ]
Sachs, L [1 ]
机构
[1] Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel
关键词
apoptosis suppression; cancer therapy; cytokines; genes and pathways of apoptosis; hematopoietic cells; leukemia; neurons;
D O I
10.1023/A:1009614723237
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Many cytokines have been isolated by their ability to induce growth and have been called growth factors. But these cytokines are also essential to induce cell viability, and cell viability and growth can be separately regulated. Using as examples myeloid hematopoietic cells, lymphocytes and neuronal cells, in vitro and in vivo studies have shown the role of cytokines in inducing viability of different cell types during development to mature cells. Some cytokines can act on more than one cell type. Cytokines induce viability of normal and cancer cells by suppressing the apoptotic machinery activated by wild-type p53, or by cytotoxic agents including irradiation and compounds used in cancer chemotherapy. Cytokines can be used to decrease apoptosis in normal cells and inhibition of cytokine activity may improve cancer therapy by enhancing apoptosis in cancer cells. The apoptosis suppressing function of cytokines is mediated by changing the balance in the activity of apoptosis inducing and suppressing genes. Apoptosis suppression is upstream of caspase activation in the apoptotic process. Cytokines can suppress multiple pathways leading to apoptosis, only some of which were suppressed by other agents such as some antioxidants, Ca2+-mobilizing compounds and protease inhibitors.
引用
收藏
页码:187 / 196
页数:10
相关论文
共 139 条
[71]   MOLECULAR-CLONING OF A LIGAND FOR THE FLT3/FLK-2 TYROSINE KINASE RECEPTOR - A PROLIFERATIVE FACTOR FOR PRIMITIVE HEMATOPOIETIC-CELLS [J].
LYMAN, SD ;
JAMES, L ;
VANDENBOS, T ;
DEVRIES, P ;
BRASEL, K ;
GLINIAK, B ;
HOLLINGSWORTH, LT ;
PICHA, KS ;
MCKENNA, HJ ;
SPLETT, RR ;
FLETCHER, FA ;
MARASKOVSKY, E ;
FARRAH, T ;
FOXWORTHE, D ;
WILLIAMS, DE ;
BECKMANN, MP .
CELL, 1993, 75 (06) :1157-1167
[72]   TARGETED DISRUPTION OF THE FLK2/FLT3 GENE LEADS TO DEFICIENCIES IN PRIMITIVE HEMATOPOIETIC PROGENITORS [J].
MACKAREHTSCHIAN, K ;
HARDIN, JD ;
MOORE, KA ;
BOAST, S ;
GOFF, SP ;
LEMISCHKA, IR .
IMMUNITY, 1995, 3 (01) :147-161
[73]   Bcl-2 can rescue T lymphocyte development in interleukin-7 receptor-deficient mice but not in mutant rag-1(-/-) mice [J].
Maraskovsky, E ;
OReilly, LA ;
Teepe, M ;
Corcoran, LM ;
Peschon, JJ ;
Strasser, A .
CELL, 1997, 89 (07) :1011-1019
[74]   DISRUPTION OF THE CNTF GENE RESULTS IN MOTOR-NEURON DEGENERATION [J].
MASU, Y ;
WOLF, E ;
HOLTMANN, B ;
SENDTNER, M ;
BREM, G ;
THOENEN, H .
NATURE, 1993, 365 (6441) :27-32
[75]   The role of calcium in the regulation of apoptosis [J].
McConkey, DJ ;
Orrenius, S .
JOURNAL OF LEUKOCYTE BIOLOGY, 1996, 59 (06) :775-783
[76]   THE GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTORS [J].
METCALF, D .
SCIENCE, 1985, 229 (4708) :16-22
[77]   PURIFICATION AND SOME CHARACTERISTICS OF HUMAN T-CELL GROWTH-FACTOR FROM PHYTOHEMAGGLUTININ-STIMULATED LYMPHOCYTE-CONDITIONED MEDIA [J].
MIER, JW ;
GALLO, RC .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1980, 77 (10) :6134-6138
[78]   INTERLEUKINS MODULATE GLUCOCORTICOID-INDUCED THYMOCYTE APOPTOSIS [J].
MIGLIORATI, G ;
PAGLIACCI, C ;
MORACA, R ;
CROCICCHIO, F ;
NICOLETTI, I ;
RICCARDI, C .
INTERNATIONAL JOURNAL OF CLINICAL & LABORATORY RESEARCH, 1992, 21 (04) :300-303
[79]   ARREST OF MOTOR-NEURON DISEASE IN WOBBLER MICE COTREATED WITH CNTF AND BDNF [J].
MITSUMOTO, H ;
IKEDA, K ;
KLINKOSZ, B ;
CEDARBAUM, JM ;
WONG, V ;
LINDSAY, RM .
SCIENCE, 1994, 265 (5175) :1107-1110
[80]  
MIYASHITA T, 1995, CELL, V80, P293